In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1661 News Items found
Through-the-microscope view of a tissue sample
MSK Research Highlights, July 17, 2023

New MSK research identified a way to reduce toxicity in CAR T cell therapy; discovered a division of labor in DNA repair that suggests a possible therapeutic strategy for certain cancers; developed a new method to enable imaging of two PET tracers simultaneously; found biomarkers that could help predict outcomes in HER2-positive metastatic esophagogastric cancer; and made progress toward improving options for patients with early-stage, potentially indolent cancers.
Once a patient, Jillian is now a breast cancer care coordinator. She shares a love story, a viral video and a special connection to the people of MSK Monmouth.
It’s Personal for Jillian Allegretti, of MSK Monmouth

Once a patient, Jillian is now a breast cancer care coordinator. She shares a love story, a viral video and a special connection to the people of MSK Monmouth.
Selwyn M. Vickers, MD, FACS
A Message From MSK’s President and CEO, Dr. Selwyn Vickers

In cancer care, firsts make a difference. At MSK, we are constantly improving how we help people with those important firsts. Dr. Selwyn Vickers writes about the latest developments at MSK and the encouraging evidence that we are making progress in our mission of ending cancer for life.
Michael Berger, PhD, Co-Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology and Elizabeth and Felix Rohatyn Chair for Junior Faculty
Exposing a Cancer Cell’s Weakness

MSK has developed an arsenal of tests that are at the front lines of precision treatments. They target the structure of proteins that cause cancer, offering people new hope.
Dr. Sohrab Shah
Fighting Cancer With Computers, Math, and Artificial Intelligence

MSK Drs. Larry Norton, Dana Pe’er, and Sohrab Shah know cancer research isn’t all beakers and test tubes — computers and algorithms are some of the most powerful tools in cancer research.
“Patients really want to feel empowered to do some­thing for their own health,” says Dr. Urvi Shah.
Food as Medicine: Why One Doctor Thinks Diet Could Help Control Cancer

When Dr. Urvi Shah was diagnosed with Hodgkin lymphoma in 2016 during her first year as a hematology-oncology fellow, she heard lots of recommendations from friends and family about what she should and shouldn’t eat.
Roxanne Joseph
New Leads in an Unsolved Mystery

After treatment for rectal cancer, Roxanne Joseph is back to enjoying an active life with her husband, Rory, and their two children. Recent research by MSK computational biologist Henry Walch is shedding light on why colorectal cancer has been more difficult to treat in many Black people.
Feature
Man examining himself.
7 Myths About Testicular Cancer

Learn how testicular cancer is often misunderstood and why it is highly treatable.
Detail shot of a scientist handling samples
MSK Research Highlights, June 29, 2023

New MSK research discovered ferroptosis regulators that suggest therapeutic opportunities against hormone receptor-positive cancers; examined how tumor-associated macrophages might be turned against cancer; acquired new insights into joint inflammation in rheumatoid arthritis; developed a systems-level platform called epichaperomics to map changes in interactors among thousands of proteins involved in cancer-related processes; and investigated how artificial intelligence could help diagnose an invasive form of breast cancer.
MSK multiple myeloma specialist Urvy Shah
Diets for MGUS, Smoldering Myeloma, and Multiple Myeloma: Q&A With MSK Cancer and Nutrition Experts

Learn how eating a plant-based diet may prevent MGUS and smoldering myeloma from developing into multiple myeloma, according to MSK research.